Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma

The matrix protein osteopontin has been shown to be a marker of osteoclastic activity in multiple myeloma patients, as well as a regulator of angiogenesis. We measured serum levels of osteopontin in 50 untreated multiple myeloma patients (in 25, also after treatment) and examined the relation to mar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sfiridaki, Aikaterini, Miyakis, Spiros, Pappa, Constantina, Tsirakis, George, Alegakis, Athanasios, Kotsis, Vasileios, Stathopoulos, Efstathios, Alexandrakis, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102033/
https://www.ncbi.nlm.nih.gov/pubmed/21548993
http://dx.doi.org/10.1186/1756-8722-4-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102033/
https://www.ncbi.nlm.nih.gov/pubmed/21548993
http://dx.doi.org/10.1186/1756-8722-4-22

Ejemplares similares